L-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes

Journal of Clinical Biochemistry and Nutrition

Volumn 59, Issue 2, 2016, Pages 93-99

  Takeshima, Mika ^a   Miyazaki, Ikuko ^a   Murakami, Shinki ^a,b   Kita, Taizo ^c   Asanuma, Masato ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b SAIDO Co   (Japan)

^c KYUSHU NUTRITION WELFARE UNIVERSITY   (Japan)

Author keywords

Astrocyte; Dopamine; Glutathione; L theanine; Neuroprotection

Indexed keywords

DOPAMINE; GLUTATHIONE; THEANINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL FREE SYSTEM; CELL VIABILITY; COCULTURE; CONDITIONED MEDIUM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GLIAL CELL CULTURE; GLUTATHIONE METABOLISM; IN VITRO STUDY; INCUBATION TIME; MALE; MESENCEPHALON; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 84988911452     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.16-15     Document Type: Article

References (40)

1. Kimura R, Murata T. Influence of alkylamides of glutamic acid and related compounds on the central nervous system. II. Syntheses of amides of gutamic acid and related compounds, and their effects on the central nervous system. Chem Pharm Bull (Tokyo) 1971; 19: 1301-1307.
2. Yokogoshi H, Kato Y, Sagesaka YM, Takihara-Matsuura T, Kakuda T, Takeuchi N. Reduction effect of theanine on blood pressure and brain 5- hydroxyindoles in spontaneously hypertensive rats. Biosci Biotechnol Biochem 1995; 59: 615-618.
3. Nishida K, Yasuda E, Nagasawa K, Fujimoto S. Altered levels of oxidation and phospholipase C isozyme expression in the brains of theanineadministered rats. Biol Pharm Bull 2008; 31: 857-860.
4. Yokozawa T, Dong E. Influence of green tea and its three major components upon low-density lipoprotein oxidation. Exp Toxicol Pathol 1997; 49: 329-335.
5. Terashima T, Takido J, Yokogoshi H. Time-dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine. Biosci Biotechnol Biochem 1999; 63: 615-618.
6. Kakuda T, Yanase H, Utsunomiya K, Nozawa A, Unno T, Kataoka K. Protective effect of gamma-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils. Neurosci Lett 2000; 289: 189-192.
7. Kakuda T, Nozawa A, Sugimoto A, Niino H. Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors. Biosci Biotechnol Biochem 2002; 66: 2683-2686.
8. Kakuda T, Hinoi E, Abe A, Nozawa A, Ogura M, Yoneda Y. Theanine, an ingredient of green tea, inhibits [3H]glutamine transport in neurons and astroglia in rat brain. J Neurosci Res 2008; 86: 1846-1856.
9. Kim TI, Lee YK, Park SG, et al. L-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: Reduction in oxidative damage and inactivation of ERK/p38 kinase and NFkappaB pathways. Free Radic Biol Med 2009; 47: 1601-1610.
10. Cho HS, Kim S, Lee SY, Park JA, Kim SJ, Chun HS. Protective effect of the green tea component, L-Theanine on environmental toxins-induced neuronal cell death. Neurotoxicology 2008; 29: 656-662.
11. Asanuma M, Miyazaki I, Ogawa N. Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotox Res 2003; 5: 165-176.
12. Lee SY, Moon Y, Hee Choi D, Jin Choi H, Hwang O. Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson's disease. Neurobiol Dis 2007; 25: 112-120.
13. Kuhn DM, Arthur RE Jr, Thomas DM, Elferink LA. Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: Possible relevance to Parkinson's disease. J Neurochem 1999; 73: 1309-1317.
14. LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. Dopamine covalently modifies and functionally inactivates parkin. Nat Med 2005; 11: 1214-1221.
15. Whitehead RE, Ferrer JV, Javitch JA, Justice JB. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. J Neurochem 2001; 76: 1242-1251.
16. Miyazaki I, Asanuma M, Diaz-Corrales FJ, Miyoshi K, Ogawa N. Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striatum and shows quenching effects on dopamine-semiquinone generated in vitro. Clin Neuropharmacol 2005; 28: 155-160.
17. Miyazaki I, Asanuma M, Diaz-Corrales FJ, et al. Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone formation-related molecules. FASEB J 2006; 20: 571-573.
18. Emdadul Haque M, Asanuma M, Higashi Y, Miyazaki I, Tanaka K, Ogawa N. Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim Biophys Acta 2003; 1619: 39-52.
19. LaVoie MJ, Hastings TG. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine. J Neurosci 1999; 19: 1484-1491.
20. Miyazaki I, Asanuma M, Kikkawa Y, et al. Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. Glia 2011; 59: 435-451.
21. Asanuma M, Miyazaki I, Diaz-Corrales FJ, et al. Neuroprotective effects of zonisamide target astrocyte. Ann Neurol 2010; 67: 239-249.
22. Iwata-Ichikawa E, Kondo Y, Miyazaki I, Asanuma M, Ogawa N. Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J Neurochem 1999; 72: 2334-2344.
23. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-522.
24. Diaz-Corrales FJ, Asanuma M, Miyazaki I, Miyoshi K, Ogawa N. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: Relevance to formation of inclusion bodies and neurodegeneration. Neuroscience 2005; 133: 117-135.
25. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH. Cystine/ glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 2006; 26: 10514-10523.
26. Wang XF, Cynader MS. Astrocytes provide cysteine to neurons by releasing glutathione. J Neurochem 2000; 74: 1434-1442.
27. Hirrlinger J, König J, Keppler D, Lindenau J, Schulz JB, Dringen R. The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. J Neurochem 2001; 76: 627-636.
28. Hirrlinger J, Schulz JB, Dringen R. Glutathione release from cultured brain cells: Multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J Neurosci Res 2002; 69: 318-326.
29. Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, Dringen R. The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem 2006; 97: 373-384.
30. Miyazaki I, Murakami S, Torigoe N, Kitamura Y, Asanuma M. Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice. J Neurochem 2016; 136: 194-204.
31. Miyazaki I, Asanuma M. Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med Okayama 2008; 62: 141-150.
32. Lai CT, Yu PH. Dopamine- And L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol 1997; 53: 363-372.
33. Kita T, Asanuma M, Miyazaki I, Takeshima M. Protective effects of phytochemical antioxidants against neurotoxin-induced degeneration of dopaminergic neurons. J Pharmacol Sci 2014; 124: 313-319.
34. Takeshima M, Murata M, Urasoe N, et al. Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity. Neurol Res 2011; 33: 1050-1056.
35. Maher P, Salgado KF, Zivin JA, Lapchak PA. A novel approach to screening for new neuroprotective compounds for the treatment of stroke. Brain Res 2007; 1173: 117-125.
36. Myhrstad MC, Carlsen H, Nordström O, Blomhoff R, Moskaug JO. Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med 2002; 32: 386-393.
37. Asatoor AM. Tea as a source of urinary ethylamine. Nature 1966; 210: 1358-1360.
38. Kurihara S, Shibahara S, Arisaka H, Akiyama Y. Enhancement of antigenspecific immunoglobulin G production in mice by co-administration of Lcystine and L-Theanine. J Vet Med Sci 2007; 69: 1263-1270.
39. Kimura K, Ozeki M, Juneja LR, Ohira H. L-Theanine reduces psychological and physiological stress responses. Biol Psychol 2007; 74: 39-45.
40. Kobayashi K, Nagato Y, Aoi N, et al. Effects of L-Theanine on the release of a-brain waves in human volunteers. Nippon Nögeikagaku Kaishi 1998; 72: 153-157.